Advanced diagnostic engineering solutions tailored for Athens and Thessaloniki clinical excellence.
High-flexibility system for custom medical device fabrication.
Aerospace-grade stability for critical laboratory assemblies.
Transforming complex diagnostic hardware manufacturing processes.
Stable performance for sensitive genetic sequencing optical modules.
Greece is currently undergoing a significant digital and clinical transformation in its healthcare sector, driven by the "Greece 2.0" National Recovery and Resilience Plan. With a focus on modernizing the National Health System (ESY) and fostering a robust medical tourism industry, the demand for Precision Medicine Diagnostic Platforms has reached an all-time high. From the research clusters in Crete (FORTH) to the clinical hubs in Athens, Greek diagnostic laboratories are transitioning from generalized treatments to targeted, biomarker-driven therapies.
As a leading factory and supplier, we recognize that the Greek market requires more than just equipment; it requires Information Gain through localized expertise and compliant technology. The integration of Next-Generation Sequencing (NGS) and automated molecular analysis is critical for managing the country's prevalent genetic conditions and improving oncology outcomes. Our platforms provide the structural and functional reliability needed to support these high-stakes medical advancements.
Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing.
With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, public health organizations, and biotechnology companies worldwide.
Supported by a multidisciplinary team of engineers, laboratory specialists, and quality management professionals, the company continuously invests in innovation and product development. Comprehensive quality control procedures are implemented throughout design, manufacturing, testing, and inspection processes to ensure consistent performance and compliance with international industry standards.
Integrating nucleic acid testing platforms with high-precision motion controls to enable rapid biomarker discovery and targeted therapy monitoring.
Supporting the Greek public health sector with automated laboratory testing systems for infectious disease tracking and pathogen detection.
Precision Z-lift and motion platforms designed for high-throughput screening of genetic variations influencing drug response.
Our R&D focuses on the convergence of Artificial Intelligence (AI) and Microfluidic Engineering. By 2026, our roadmap includes the full integration of "Lab-on-a-Chip" technologies within our 3D flexible platforms, allowing Greek medical institutions to perform complex genetic sequencing with 50% less reagent waste and 30% faster analytical speed.
Navigating the EU In Vitro Diagnostic Regulation (IVDR 2017/746) is a critical challenge for Greek laboratory directors. BioX Medical ensures that all platforms serving the Mediterranean region are designed with rigorous adherence to CE-IVD standards. Our global procurement model offers:
Yes, all our clinical laboratory equipment is manufactured under ISO 13485:2016 quality management systems and meets the necessary CE-IVD requirements for use within the Hellenic Republic and the wider European Union.
Our automated systems feature advanced data management capabilities with HL7 and DICOM compatibility, ensuring seamless integration with Greek hospital informatics infrastructures.
Standard platforms typically ship within 4-6 weeks. For custom OEM solutions, the timeline varies based on engineering complexity, but we prioritize Greek medical infrastructure projects to ensure timely deployment.
We provide 24/7 remote technical diagnostics and partner with regional distributors in Greece to offer on-the-ground maintenance and calibration services.
High-load bearing structures, robotic integration platforms, and specialized lifting equipment for modern labs.
Essential for precision medical hardware assembly.
Optimized for temperature-sensitive molecular assays.
Automating the manufacturing of diagnostic housing components.
Stable support for heavy-duty sequencing machines.
Rigid continuous lifting machine for multi-level lab automation.
Micro-adjustments for high-resolution genetic imaging.
Automated Z-axis control for sample handling robotics.
Multipurpose engineering platform for medical device prototyping.
Available for specialized motion platforms: Six Degree of Freedom Motion Platform, Stainless Steel Weighing Platform, Quick Assembly 3D Platform, and Hydraulic Work Platforms.
Send Inquiry NowShenzhen BioX Medical Co., Ltd. continues to strive for the global evolution of molecular diagnostics. By delivering reliable, scalable, and innovative diagnostic systems, we support disease detection, genetic analysis, and precision healthcare initiatives throughout Greece and the global medical community.
BioX Medical